Detailed information for compound 29445

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 281.371 | Formula: C14H19NO3S
  • H donors: 1 H acceptors: 3 LogP: 2.4 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: SCC(C(=O)N(c1c(C)cccc1C)CC(=O)O)C
  • InChi: 1S/C14H19NO3S/c1-9-5-4-6-10(2)13(9)15(7-12(16)17)14(18)11(3)8-19/h4-6,11,19H,7-8H2,1-3H3,(H,16,17)
  • InChiKey: NPVQRZQXZPCUFX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Oryctolagus cuniculus Angiotensin-converting enzyme Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi Angiotensin-converting enzyme family protein Get druggable targets OG5_131988 All targets in OG5_131988
Loa Loa (eye worm) angiotensin-converting enzyme family protein Get druggable targets OG5_131988 All targets in OG5_131988

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Wolbachia endosymbiont of Brugia malayi peptide deformylase 1.039 1 0.5
Onchocerca volvulus Matrilysin homolog 0.0405 0.0144 1
Loa Loa (eye worm) angiotensin-converting enzyme family protein 0.0749 0.0483 0.7391
Echinococcus multilocularis adam 17 protease 0.0414 0.0153 0.3812
Loa Loa (eye worm) hypothetical protein 0.087 0.0603 1
Echinococcus granulosus adam 17 protease 0.0455 0.0194 0.4832
Leishmania major polypeptide deformylase-like protein, putative 0.3965 0.3658 0.5
Plasmodium falciparum peptide deformylase 1.039 1 0.5
Mycobacterium ulcerans peptide deformylase 1.039 1 0.5
Echinococcus multilocularis matrix metallopeptidase 7 (M10 family) 0.0664 0.04 1
Trypanosoma brucei Polypeptide deformylase 1 0.3965 0.3658 0.5
Plasmodium vivax peptide deformylase, putative 1.039 1 0.5
Onchocerca volvulus Matrix metalloproteinase homolog 0.0405 0.0144 1
Echinococcus granulosus matrix metallopeptidase 7 M10 family 0.0664 0.04 1
Trypanosoma brucei Peptide deformylase 2 0.3965 0.3658 0.5
Mycobacterium tuberculosis Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) 1.039 1 1
Loa Loa (eye worm) matrixin family protein 0.0442 0.018 0.0786
Brugia malayi Matrixin family protein 0.0442 0.018 0.3732
Schistosoma mansoni ADAM17 peptidase (M12 family) 0.0414 0.0153 1
Treponema pallidum polypeptide deformylase (def) 1.039 1 0.5
Trypanosoma cruzi polypeptide deformylase-like protein, putative 0.3965 0.3658 0.5
Trypanosoma cruzi polypeptide deformylase-like protein, putative 0.3965 0.3658 0.5
Trypanosoma cruzi Peptide deformylase 2, putative 0.3965 0.3658 0.5
Mycobacterium leprae PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) 1.039 1 0.5
Brugia malayi Angiotensin-converting enzyme family protein 0.0749 0.0483 1
Toxoplasma gondii hypothetical protein 1.039 1 0.5
Trypanosoma cruzi Peptide deformylase 2, putative 0.3965 0.3658 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 1901 nM In vitro inhibition of Angiotensin I converting enzyme ChEMBL. 6310112
IC50 (binding) = 1901 nM In vitro inhibition of Angiotensin I converting enzyme ChEMBL. 6310112

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.